Todos Medical Ltd. is a developer and distributor of medical diagnostics addressing cancers, Alzheimer’s Disease and viruses, as well as a provider of Covid-19 testing supplies and automation solutions, and a developer and distributor of immune support products and antivirals that target the inhibition of 3CL protease for the treatment of Covid-19.
CEO & Director
Gerald Commissiong has served as our Chief Executive Officer and member of the Board of Directors of Todos Medical since January 5, 2020. He has over a decade of experience in therapeutic and diagnostic development, including all aspects of product licensing, research collaborations, and go-to-market strategies. He is the former CEO and co-founder of Amarantus Bioscience, a company that developed LymPro, an Alzheimer’s diagnostic currently being advanced by Todos Medical. Mr. Commissiong has raised over $70 million in research capital to forward numerous scientific development programs, including those currently underway at Todos. He is a former professional football player for the Calgary Stampeders of the Canadian Football League who received a Bachelor of Science degree in Management Science and Engineering with a focus in Financial Decisions from Stanford University.